First-line treatment for cutaneous leishmaniasis in India according to current guidelines is:

• A Intralesional sodium stibogluconate ✓
• B Oral miltefosine for 28 days
• C Topical paromomycin ointment
• D Intravenous amphotericin B

Explanation

For localised cutaneous leishmaniasis, intralesional sodium stibogluconate (SSG) is the first-line treatment, given weekly until healing. Oral miltefosine is reserved for extensive or treatment-resistant cases. IV amphotericin B (liposomal) is used for visceral leishmaniasis (kala-azar), not for simple cutaneous disease. Topical paromomycin is used in some geographical settings but is not first-line in India.

Reference: Neena Khanna Illustrated Synopsis of Dermatology & STD, 6th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.